Evidence map›Paper›PMID 28720557›Full record

ArticleJMIR research protocols2017

Comparing Mobile Health Strategies to Improve Medication Adherence for Veterans With Coronary Heart Disease (Mobile4Meds): Protocol for a Mixed-Methods Study.

Linda G Park, Eileen G Collins, Janet K Shim, Mary A Whooley

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03022669 (Mobile Health Strategies for Veterans With Coronary Heart Disease), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03022669 naunknown statusnot on this map

Mobile Health Strategies for Veterans With Coronary Heart Disease

TypeinterventionalSponsorSan Francisco Veterans Affairs Medical CenterRan2016 to 2022Enrolled225ConditionsCoronary Heart DiseaseArmsText Message, Mobile Application, Website
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Linda G ParkDepartment of Veterans Affairs, Community Health Systems, University of California, San Francisco, San Francisco, CA, United States.ORCID http://orcid.org/0000-0002-9894-4039
Eileen G CollinsEdward Hines Jr., VA Hospital, Department of Biobehavioral Health Science, University of Illinois at Chicago, Chicago, IL, United States.ORCID http://orcid.org/0000-0003-1302-7264
Janet K ShimUniversity of California, San Francisco, Social and Behavioral Sciences, San Francisco, CA, United States.ORCID http://orcid.org/0000-0002-4597-7961
Mary A WhooleyDepartment of Veterans Affairs, Department of Medicine, Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.ORCID http://orcid.org/0000-0002-5943-0078
San Francisco VA Medical Center · USEdward Hines, Jr. VA Hospital · USUniversity of California, San Francisco · US

Funding

Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Institutional Career Development Core SupplementKL2TR001870 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANAYA, ALKA M., SARKAR, URMIMALA · 2016 to 2025
$19.7M
Mobile Health Strategies for Veterans with Coronary Heart DiseaseIK3HX002055 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI PARK, LINDA GRACE · 2018 to 2023
–
HSRD VA IK3 HX002055NCATS NIH HHS KL2 TR001870NCATS NIH HHS UL1 TR000004
6 · The paper itself

Abstract

backgroundAdherence to antiplatelet medications is critical to prevent life threatening complications (ie, stent thrombosis) after percutaneous coronary interventions (PCIs), yet rates of nonadherence range from 21-57% by 12 months. Mobile interventions delivered via text messaging or mobile apps represent a practical and inexpensive strategy to promote behavior change and enhance medication adherence.

objectiveThe Mobile4Meds study seeks to determine whether text messaging or a mobile app, compared with an educational website control provided to all Veterans, can improve adherence to antiplatelet therapy among patients following acute coronary syndrome (ACS) or PCI. The three aims of the study are to: (1) determine preferences for content and frequency of text messaging to promote medication adherence through focus groups; (2) identify the most patient-centered app that promotes adherence, through a content analysis of all commercially available apps for medication adherence and focus groups centered on usability; and (3) compare adherence to antiplatelet medications in Veterans after ACS/PCI via a randomized clinical trial (RCT).

methodsWe will utilize a mixed-methods design that uses focus groups to achieve the first and second aims (N=32). Patients will be followed for 12 months after being randomly assigned to one of three arms: (1) customized text messaging, (2) mobile app, or (3) website-control groups (N=225). Medication adherence will be measured with electronic monitoring devices, pharmacy records, and self-reports.

resultsEnrollment for the focus groups is currently in progress. We expect to enroll patients for the RCT in the beginning of 2018.

conclusionsDetermining the efficacy of mobile technology using a Veteran-designed protocol to promote medication adherence will have a significant impact on Veteran health and public health, particularly for individuals with chronic diseases that require strict medication adherence.

trial registrationClinicalTrials.gov NCT03022669.

Indexed as

adherencecardiovascular diseasemedicationmobile applicationmobile healthtext messaging

Identifiers

PMID28720557
PMCPMC5539386
OpenAlexW2738396629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.